Inhibiting the conversion of soluble amyloid-beta peptide into abnormally folded amyloidogenic intermediates: relevance for Alzheimer's disease therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/11261811

Download in:

View as

Triples

General Info

PMID
11261811